CBT — Cabot Corporation
Is CBT overbought or oversold? Here is the current MarketMoodz read.
Cabot Corporation (CBT) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Basic Materials name (Specialty Chemicals) last closed at $70.14. The rating moved from Strong Oversold to Oversold on November 12, 2026.
- Public ratingOversold (as of November 17, 2026)
- Last close$70.14
- Last changeMoved from Strong Oversold to Oversold on November 12, 2026
- SectorBasic Materials
- IndustrySpecialty Chemicals
See all oversold Basic Materials stocks →
AI analysis
Cabot Corporation combines a diversified specialty-chemicals portfolio with exposure to higher-value industrial end-markets. Near-term performance will hinge on industrial and automotive demand, raw-material cost trends, and execution on operational initiatives; absent material company-specific filings in the dataset, there is moderate confidence that Cabot can deliver upside versus current levels but meaningful downside remains if macro or input-cost shocks occur.
Key factors
- Leading specialty-chemicals and performance-materials portfolio with applications in coatings, rubber, activated carbon and other industrial end-markets
- Sector-level consolidation and cost-savings initiatives in coatings & specialty chemicals creating potential valuation and margin upside
- Exposure to secular growth end-markets (advanced materials, some battery/EV-related applications) supporting mid‑cycle demand
- Diversified end-market exposure that can mitigate weakness in any single cyclical segment
- Operational efficiency programs and historically steady cash-generation profile that support investment and optionality
- Relative resilience in pricing and margins versus commodity chemicals, giving some downside protection in softer macro environments
Risks
- Cyclicality in automotive and industrial end-markets could reduce volumes and pricing power
- Raw-material and energy price volatility (feedstock, oil, gas) can compress margins quickly
- Environmental, remediation and regulatory liabilities specific to carbon/chemical operations could drive unexpected costs
- Execution risk on any M&A, restructuring or capital allocation initiatives
- FX, trade disruptions or weaker global manufacturing growth could impair international sales
- Limited near-term company-specific disclosure in the provided dataset increases short-term uncertainty
See today's live rating, score and targets
Members see the live hourly rating for CBT — the numeric AI score plus targets and entry zones — while this public page updates nightly.
Start the 14-day trialThis page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.